CLOs on the Move

VITAS Healthcare

www.vitas.com

 
VITAS Innovative Hospice Care, a pioneer and leader in the hospice movement since 1978, is the one of the nations largest providers of end-of-life care.
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.vitas.com
  • 201 South Biscayne Blvd #400
    Miami, FL USA 33131
  • Phone: 305.374.4143

Executives

Name Title Contact Details

Similar Companies

TOMLYN PRODUCTS

TOMLYN PRODUCTS is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wellpoint Health Services

Wellpoint Health Services is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Atlantic Medical Imaging

Atlantic Medical Imaging is a quality-driven medical imaging practice committed to clinical excellence by providing innovative service and compassionate care that exceeds expectations.

Siemens Healthcare

Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to meet their current challenges and to excel in their respective environments. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. To help customers succeed in today`s dynamic healthcare marketplace, Siemens Healthineers is championing new business models that maximize opportunity and minimize risk for healthcare providers.

SetPoint Medical

SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.